糖尿病领域专利技术申请资料汇编（三）.doc

糖尿病领域专利技术申请资料汇编（三） 申请(专利权)人 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (JP) (All Except Us) Nippon Kayaku Kabushiki Kaisha (JP) (All Except Us) Takeuchi Tomio (JP) (Us Only) Muraoka Yasuhiko (JP) (Us Only) Akiyama Tetsuo (JP) (Us Only) Abe Masatoshi (JP) (Us Only) 发明(设计)人 Takeuchi Tomio(JP) Muraoka Yasuhiko(JP) Akiyama Tetsuo(JP) Abe Masatoshi(JP) 代理人 ASAMURA Kiyoshi(JP) 国际专利分类码 A61K 31/675  专利局: 世界知识产权组织PCT专利 (WIPO) ?? 标题: (EN) Therapeutic agent for type 2 diabetes (JA) ２型糖尿病治療剤  申请编号: PCT/JP2003/007928 公开编号: 2004/000327 申请日期: 2003-06-23 公开日期: 2003-12-31 摘要 (EN) A therapeutic agent for type 2 diabetes which contains a sulphostin derivative represented by the general formula (1): (1) (wherein n is an integer of 0 to 3) or a pharmacologically acceptable salt of the derivative as an active ingredient.(JA) not available 申请(专利权)人 Japan Science And Technology Agency (JP) (All Except Us) Shichiri Masayoshi (JP) (Us Only) Tanaka Yujiro (JP) (Us Only) 发明(设计)人 Shichiri Masayoshi(JP) Tanaka Yujiro(JP) 代理人 HIROTA Masanori(JP) 国际专利分类码 A61K 31/395 A61K 31/496  专利局: 世界知识产权组织PCT专利 (WIPO) ?? 标题: (EN) Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor (JA) アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法  申请编号: PCT/JP2003/007813 公开编号: 2004/000307 申请日期: 2003-06-19 公开日期: 2003-12-31 摘要 (EN) It is intended to provide a novel angiogenesis inhibitor which is efficacious against angiogenesis in various diseases, highly safe and highly useful in practice; and a method of screening the same. The angiogenesis inhibitor comprises, as the active ingredient, an ansamycin antibiotic such as rifampicin, rifamycin SV or 3-formyl rifamycin having been widely employed as an antibacterial agent in treating tuberculosis or infections with gram-positive bacteria. Such an active ingredient has an excellent effect of inhibiting angiogenesis. The angiogenesis inhibitor is efficacious in inhibiting ang